Loading...
Off-label drug promotion and the ephemeral line between marketing and education
Fueled by massive settlements and concerns about pharmaceutical company influence over medical practice, the fight over off-label promotion has become a rancorous one with little middle ground. For some, off-label restrictions are both bad law and bad medicine, violating the First Amendment while de...
Na minha lista:
| Udgivet i: | J Law Biosci |
|---|---|
| Hovedforfatter: | |
| Format: | Artigo |
| Sprog: | Inglês |
| Udgivet: |
Oxford University Press
2015
|
| Fag: | |
| Online adgang: | https://ncbi.nlm.nih.gov/pmc/articles/PMC5034393/ https://ncbi.nlm.nih.gov/pubmed/27774219 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1093/jlb/lsv052 |
| Tags: |
Tilføj Tag
Ingen Tags, Vær først til at tagge denne postø!
|